Skip to content

Friday, May 29, 2020

Is a vaccine candidate that protected monkeys from MERS being tested against COVID-19?

Remaya Campbell, Gigafact Foundry

yes

An April 2020 study showed that a vaccine candidate developed in response to the 2012 Middle East Respiratory Syndrome epidemic was effective in combating MERS in rhesus macaque monkeys, which are genetically similar to humans.

The potential MERS vaccine, ChAdOx1 nCoV-19, is now being tested in human trials in the U.K. and Saudi Arabia to determine whether it might be effective against COVID-19, which is related to the MERS-CoV coronavirus.

The trial has received U.K. government support and drawn the participation of AstraZeneca, a large pharmaceutical company. Researchers involved in the vaccine trials say results are at least six months away.

About fact briefs

Fact briefs are bite-sized, well-sourced explanations that offer clear "yes" or "no" answers to questions, confusions, and unsupported claims circulating online. They rely on publicly available data and documents, often from the original source. Fact briefs are written and published by newsrooms in the Gigafact network.

See all fact briefs

Between 2020 and 2022, under close editorial supervision, Gigafact contracted a group of freelance writers and editors to test the concepts for fact briefs and provide inputs to our software development process. We call this effort Gigafact Foundry. Over the course of these two years, Gigafact Foundry writers published over 1500 fact briefs in response to claims they found online. Their important work forms the basis of Gigafact formats and editorial guidelines, and is available to the public on Gigafact.org. Readers should be aware that while there is still a lot of relevant information to be found, not all fact briefs produced by Gigafact Foundry reflect Gigafact's current methods and standards for fact briefs. If you come across any that you feel are out of date and need to be looked at with fresh eyes, don't hesitate to contact us at support@gigafact.org.

Learn More

Be a Friend of facts

Help us fund more great fact briefs like this one.